Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease

Gait disorders and postural instability, which are commonly observed in elderly patients with Parkinson disease (PD), respond poorly to dopaminergic agents used to treat other parkinsonian symptoms. The brain structures underlying gait disorders and falls in PD and aging remain to be characterized....

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 120; no. 8; pp. 2745 - 2754
Main Authors Karachi, Carine, Grabli, David, Bernard, Frédéric A., Tandé, Dominique, Wattiez, Nicolas, Belaid, Hayat, Bardinet, Eric, Prigent, Annick, Nothacker, Hans-Peter, Hunot, Stéphane, Hartmann, Andreas, Lehéricy, Stéphane, Hirsch, Etienne C., François, Chantal
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.08.2010
Subjects
Online AccessGet full text
ISSN0021-9738
1558-8238
1558-8238
DOI10.1172/JCI42642

Cover

More Information
Summary:Gait disorders and postural instability, which are commonly observed in elderly patients with Parkinson disease (PD), respond poorly to dopaminergic agents used to treat other parkinsonian symptoms. The brain structures underlying gait disorders and falls in PD and aging remain to be characterized. Using functional MRI in healthy human subjects, we have shown here that activity of the mesencephalic locomotor region (MLR), which is composed of the pedunculopontine nucleus (PPN) and the adjacent cuneiform nucleus, was modulated by the speed of imagined gait, with faster imagined gait activating a discrete cluster within the MLR. Furthermore, the presence of gait disorders in patients with PD and in aged monkeys rendered parkinsonian by MPTP intoxication correlated with loss of PPN cholinergic neurons. Bilateral lesioning of the cholinergic part of the PPN induced gait and postural deficits in nondopaminergic lesioned monkeys. Our data therefore reveal that the cholinergic neurons of the PPN play a central role in controlling gait and posture and represent a possible target for pharmacological treatment of gait disorders in PD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Authorship note: Carine Karachi and David Grabli contributed equally to this work.
ISSN:0021-9738
1558-8238
1558-8238
DOI:10.1172/JCI42642